Quick Links

11. Yao, X., et al; InVitro Antiviral Activity and Projection of Optimized Dosing Design ofHydroxychloroquine for the Treatment of Severe Acute Respiratory SyndromeCoronavirus 2 (SARS-CoV-2), March 9 2020, Clinical Infectious Diseases, ciaa237,https://doi.org/10.1093/cid/ciaa237

2 Rosenberg ES., et al;Association of Treatment With Hydroxychloroquine or Azithromycin WithIn-Hospital Mortality in Patients With COVID-19 in New York State JAMA. Published online May 11,2020. doi:10.1001/jama.2020.8630

3Tett SE., et al;Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J ClinPharmacol. 1989l27 (6) 771-779

4Huang,X., et al; The Role of Macrophages in the Pathogenesis of ALI/ARDS. MediatorsInflamm. (2018): 1264913.